anmelden
FTSE 100
10.812,70
PKT
+20,16
PKT
+0,19
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.11.23 | National Grid Neutral | Goldman Sachs Group Inc. | |
| 09.11.23 | National Grid Neutral | Goldman Sachs Group Inc. | |
| 09.11.23 | National Grid Outperform | RBC Capital Markets | |
| 09.11.23 | National Grid Neutral | UBS AG | |
| 09.11.23 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 09.11.23 | Unilever Overweight | Barclays Capital | |
| 08.11.23 | Unilever Buy | Deutsche Bank AG | |
| 08.11.23 | Diageo Overweight | JP Morgan Chase & Co. | |
| 08.11.23 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.11.23 | Unilever Sector Perform | RBC Capital Markets | |
| 07.11.23 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.11.23 | Shell (ex Royal Dutch Shell) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.11.23 | Diageo Sell | Deutsche Bank AG | |
| 07.11.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 06.11.23 | BP Buy | Goldman Sachs Group Inc. | |
| 03.11.23 | Shell (ex Royal Dutch Shell) Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.11.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.11.23 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 02.11.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.11.23 | Diageo Overweight | JP Morgan Chase & Co. | |
| 02.11.23 | Unilever Underweight | JP Morgan Chase & Co. | |
| 02.11.23 | BAT Neutral | JP Morgan Chase & Co. | |
| 02.11.23 | Shell (ex Royal Dutch Shell) Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.11.23 | GSK Buy | Deutsche Bank AG | |
| 02.11.23 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 02.11.23 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 02.11.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.11.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 02.11.23 | BP Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.11.23 | GSK Sell | UBS AG | |
| 01.11.23 | HSBC Neutral | UBS AG | |
| 01.11.23 | GSK Hold | Jefferies & Company Inc. | |
| 01.11.23 | BP Buy | Goldman Sachs Group Inc. | |
| 01.11.23 | BP Underweight | JP Morgan Chase & Co. | |
| 31.10.23 | HSBC Outperform | RBC Capital Markets | |
| 31.10.23 | HSBC Overweight | Barclays Capital | |
| 31.10.23 | BP Neutral | JP Morgan Chase & Co. | |
| 31.10.23 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 31.10.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 31.10.23 | Vodafone Group Buy | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.
